Filing Flows

Filing Flows › Dentsply Sirona (XRAY) › Q2 2026

Dentsply Sirona (XRAY) Q2 2026 earnings results (second quarter 2026)

10-Q filed Aug 6, 2026

Dentsply Sirona (XRAY) reported revenue of $898M for the second quarter 2026 (Q2 2026), -4% from a year earlier and +2% from the quarter before. Operating margin was 9.1%, net earnings $37.0M (4.1% of revenue).

Revenue$898M
Year over year-4%
Quarter over quarter+2%
Operating margin9.1%
Net earnings$37.0M

Dentsply Sirona, Q2 2026: revenue $898M (-4% year over year), operating margin 9.1%, net earnings $37.0M, operating cash flow $99.0M. The chart follows the revenue to costs, profit and cash.

Q2 2026AmountQ/QY/Y
Revenue$898M+2%-4%
Gross profit$493M+15%+0.6%
Operating profit$82.0M——
Net earnings$37.0M——
Operating cash flow$99.0M+148%+106%
Free cash flow$55.0M—+244%

What changed

Revenue was $898.0M in Q2 2026, down 4% year over year and up 2% from the previous quarter.

Gross margin was 54.9%, up 2.5 points from Q2 2025. Operating profit was $82.0M, a 9.1% margin (up 22.8 points year over year). Operating expenses fell 33% while revenue fell 4%. The fastest-growing cost line was Research & development (+22%). Net earnings were $37.0M ($36.0M including minority interests, which bore $1.0M of losses). The effective tax rate was 50.0%.

Operating cash flow was $99.0M (up 106% year over year), 275% of net income including minority interests. Non-cash charges added back $85.0M of depreciation and amortization and $9.0M of share-based compensation. Working capital and other items used $31.0M. Capital expenditures of $44.0M left free cash flow of $55.0M.

Questions

What was Dentsply Sirona's revenue in the second quarter 2026?

Dentsply Sirona (XRAY) reported revenue of $898M for the second quarter 2026 (Q2 2026), -4% from a year earlier and +2% from the quarter before.

Was Dentsply Sirona profitable in the second quarter 2026?

Operating profit was $82.0M (9.1% of revenue) and net earnings $37.0M.

Open the interactive Sankey →

Source: Dentsply Sirona 10-Q on SEC EDGAR.